Report Detail

Other Global Gamma-Aminobutyric Acid (GABA) Receptor Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM2772956
  • |
  • 17 January, 2019
  • |
  • Global
  • |
  • 136 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

Gamma-Aminobutyric acid (GABA) is an important inhibitory neurotransmitter found in the central nervous system of mammals. The neurotransmitter reduces the activity of neurons to which it binds, thus is used to control anxiety or fear when neurons are overexcited. GABA receptors are protein molecules that respond to neurotransmitter GABA.

Scope of the Report:
This report focuses on the Gamma-Aminobutyric Acid (GABA) Receptor in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Gamma-Aminobutyric Acid (GABA) Receptor is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
Advicenne
AstraZeneca
Athena Drug Delivery Solutions
Biocodex
Elan Corporation
Eli Lilly & Company
H.LundBeck
GlaxoSmithKline
NovaDel Pharma
Novartis
OVATION Pharmaceuticals
Osmotica Pharmaceutical
Pfizer
sanofi-aventis
VIVUS
XenoPort

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
GABAA
GABAB

Market Segment by Applications, can be divided into
Attention Deficit Hyperactivity Disorder
Psychiatric Disorders
Alzheimer's Disease
Chronic Obstructive Pulmonary Disease
Memory Impairment
Other

There are 15 Chapters to deeply display the global Gamma-Aminobutyric Acid (GABA) Receptor market.
Chapter 1, to describe Gamma-Aminobutyric Acid (GABA) Receptor Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Gamma-Aminobutyric Acid (GABA) Receptor, with sales, revenue, and price of Gamma-Aminobutyric Acid (GABA) Receptor, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Gamma-Aminobutyric Acid (GABA) Receptor, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Gamma-Aminobutyric Acid (GABA) Receptor market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Gamma-Aminobutyric Acid (GABA) Receptor sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source


Table of Contents

    1 Market Overview

    • 1.1 Gamma-Aminobutyric Acid (GABA) Receptor Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 GABAA
      • 1.2.2 GABAB
    • 1.3 Market Analysis by Applications
      • 1.3.1 Attention Deficit Hyperactivity Disorder
      • 1.3.2 Psychiatric Disorders
      • 1.3.3 Alzheimer's Disease
      • 1.3.4 Chronic Obstructive Pulmonary Disease
      • 1.3.5 Memory Impairment
      • 1.3.6 Other
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2013-2023)
        • 1.4.1.2 Canada Market States and Outlook (2013-2023)
        • 1.4.1.3 Mexico Market States and Outlook (2013-2023)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2013-2023)
        • 1.4.2.2 France Market States and Outlook (2013-2023)
        • 1.4.2.3 UK Market States and Outlook (2013-2023)
        • 1.4.2.4 Russia Market States and Outlook (2013-2023)
        • 1.4.2.5 Italy Market States and Outlook (2013-2023)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2013-2023)
        • 1.4.3.2 Japan Market States and Outlook (2013-2023)
        • 1.4.3.3 Korea Market States and Outlook (2013-2023)
        • 1.4.3.4 India Market States and Outlook (2013-2023)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2013-2023)
        • 1.4.4.2 Egypt Market States and Outlook (2013-2023)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
        • 1.4.4.4 South Africa Market States and Outlook (2013-2023)
        • 1.4.4.5 Nigeria Market States and Outlook (2013-2023)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Advicenne
      • 2.1.1 Business Overview
      • 2.1.2 Gamma-Aminobutyric Acid (GABA) Receptor Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Advicenne Gamma-Aminobutyric Acid (GABA) Receptor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.2 AstraZeneca
      • 2.2.1 Business Overview
      • 2.2.2 Gamma-Aminobutyric Acid (GABA) Receptor Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 AstraZeneca Gamma-Aminobutyric Acid (GABA) Receptor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.3 Athena Drug Delivery Solutions
      • 2.3.1 Business Overview
      • 2.3.2 Gamma-Aminobutyric Acid (GABA) Receptor Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Athena Drug Delivery Solutions Gamma-Aminobutyric Acid (GABA) Receptor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.4 Biocodex
      • 2.4.1 Business Overview
      • 2.4.2 Gamma-Aminobutyric Acid (GABA) Receptor Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Biocodex Gamma-Aminobutyric Acid (GABA) Receptor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.5 Elan Corporation
      • 2.5.1 Business Overview
      • 2.5.2 Gamma-Aminobutyric Acid (GABA) Receptor Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Elan Corporation Gamma-Aminobutyric Acid (GABA) Receptor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.6 Eli Lilly & Company
      • 2.6.1 Business Overview
      • 2.6.2 Gamma-Aminobutyric Acid (GABA) Receptor Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Eli Lilly & Company Gamma-Aminobutyric Acid (GABA) Receptor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.7 H.LundBeck
      • 2.7.1 Business Overview
      • 2.7.2 Gamma-Aminobutyric Acid (GABA) Receptor Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 H.LundBeck Gamma-Aminobutyric Acid (GABA) Receptor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.8 GlaxoSmithKline
      • 2.8.1 Business Overview
      • 2.8.2 Gamma-Aminobutyric Acid (GABA) Receptor Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 GlaxoSmithKline Gamma-Aminobutyric Acid (GABA) Receptor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.9 NovaDel Pharma
      • 2.9.1 Business Overview
      • 2.9.2 Gamma-Aminobutyric Acid (GABA) Receptor Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 NovaDel Pharma Gamma-Aminobutyric Acid (GABA) Receptor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.10 Novartis
      • 2.10.1 Business Overview
      • 2.10.2 Gamma-Aminobutyric Acid (GABA) Receptor Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Novartis Gamma-Aminobutyric Acid (GABA) Receptor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.11 OVATION Pharmaceuticals
      • 2.11.1 Business Overview
      • 2.11.2 Gamma-Aminobutyric Acid (GABA) Receptor Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 OVATION Pharmaceuticals Gamma-Aminobutyric Acid (GABA) Receptor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.12 Osmotica Pharmaceutical
      • 2.12.1 Business Overview
      • 2.12.2 Gamma-Aminobutyric Acid (GABA) Receptor Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Osmotica Pharmaceutical Gamma-Aminobutyric Acid (GABA) Receptor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.13 Pfizer
      • 2.13.1 Business Overview
      • 2.13.2 Gamma-Aminobutyric Acid (GABA) Receptor Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Pfizer Gamma-Aminobutyric Acid (GABA) Receptor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.14 sanofi-aventis
      • 2.14.1 Business Overview
      • 2.14.2 Gamma-Aminobutyric Acid (GABA) Receptor Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 sanofi-aventis Gamma-Aminobutyric Acid (GABA) Receptor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.15 VIVUS
      • 2.15.1 Business Overview
      • 2.15.2 Gamma-Aminobutyric Acid (GABA) Receptor Type and Applications
        • 2.15.2.1 Product A
        • 2.15.2.2 Product B
      • 2.15.3 VIVUS Gamma-Aminobutyric Acid (GABA) Receptor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.16 XenoPort
      • 2.16.1 Business Overview
      • 2.16.2 Gamma-Aminobutyric Acid (GABA) Receptor Type and Applications
        • 2.16.2.1 Product A
        • 2.16.2.2 Product B
      • 2.16.3 XenoPort Gamma-Aminobutyric Acid (GABA) Receptor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    3 Global Gamma-Aminobutyric Acid (GABA) Receptor Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

    • 3.1 Global Gamma-Aminobutyric Acid (GABA) Receptor Sales and Market Share by Manufacturer (2016-2017)
    • 3.2 Global Gamma-Aminobutyric Acid (GABA) Receptor Revenue and Market Share by Manufacturer (2016-2017)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Gamma-Aminobutyric Acid (GABA) Receptor Manufacturer Market Share in 2017
      • 3.3.2 Top 6 Gamma-Aminobutyric Acid (GABA) Receptor Manufacturer Market Share in 2017
    • 3.4 Market Competition Trend

    4 Global Gamma-Aminobutyric Acid (GABA) Receptor Market Analysis by Regions

    • 4.1 Global Gamma-Aminobutyric Acid (GABA) Receptor Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Gamma-Aminobutyric Acid (GABA) Receptor Sales and Market Share by Regions (2013-2018)
      • 4.1.2 Global Gamma-Aminobutyric Acid (GABA) Receptor Revenue and Market Share by Regions (2013-2018)
    • 4.2 North America Gamma-Aminobutyric Acid (GABA) Receptor Sales and Growth Rate (2013-2018)
    • 4.3 Europe Gamma-Aminobutyric Acid (GABA) Receptor Sales and Growth Rate (2013-2018)
    • 4.4 Asia-Pacific Gamma-Aminobutyric Acid (GABA) Receptor Sales and Growth Rate (2013-2018)
    • 4.5 South America Gamma-Aminobutyric Acid (GABA) Receptor Sales and Growth Rate (2013-2018)
    • 4.6 Middle East and Africa Gamma-Aminobutyric Acid (GABA) Receptor Sales and Growth Rate (2013-2018)

    5 North America Gamma-Aminobutyric Acid (GABA) Receptor by Countries

    • 5.1 North America Gamma-Aminobutyric Acid (GABA) Receptor Sales, Revenue and Market Share by Countries
      • 5.1.1 North America Gamma-Aminobutyric Acid (GABA) Receptor Sales and Market Share by Countries (2013-2018)
      • 5.1.2 North America Gamma-Aminobutyric Acid (GABA) Receptor Revenue and Market Share by Countries (2013-2018)
    • 5.2 United States Gamma-Aminobutyric Acid (GABA) Receptor Sales and Growth Rate (2013-2018)
    • 5.3 Canada Gamma-Aminobutyric Acid (GABA) Receptor Sales and Growth Rate (2013-2018)
    • 5.4 Mexico Gamma-Aminobutyric Acid (GABA) Receptor Sales and Growth Rate (2013-2018)

    6 Europe Gamma-Aminobutyric Acid (GABA) Receptor by Countries

    • 6.1 Europe Gamma-Aminobutyric Acid (GABA) Receptor Sales, Revenue and Market Share by Countries
      • 6.1.1 Europe Gamma-Aminobutyric Acid (GABA) Receptor Sales and Market Share by Countries (2013-2018)
      • 6.1.2 Europe Gamma-Aminobutyric Acid (GABA) Receptor Revenue and Market Share by Countries (2013-2018)
    • 6.2 Germany Gamma-Aminobutyric Acid (GABA) Receptor Sales and Growth Rate (2013-2018)
    • 6.3 UK Gamma-Aminobutyric Acid (GABA) Receptor Sales and Growth Rate (2013-2018)
    • 6.4 France Gamma-Aminobutyric Acid (GABA) Receptor Sales and Growth Rate (2013-2018)
    • 6.5 Russia Gamma-Aminobutyric Acid (GABA) Receptor Sales and Growth Rate (2013-2018)
    • 6.6 Italy Gamma-Aminobutyric Acid (GABA) Receptor Sales and Growth Rate (2013-2018)

    7 Asia-Pacific Gamma-Aminobutyric Acid (GABA) Receptor by Countries

    • 7.1 Asia-Pacific Gamma-Aminobutyric Acid (GABA) Receptor Sales, Revenue and Market Share by Countries
      • 7.1.1 Asia-Pacific Gamma-Aminobutyric Acid (GABA) Receptor Sales and Market Share by Countries (2013-2018)
      • 7.1.2 Asia-Pacific Gamma-Aminobutyric Acid (GABA) Receptor Revenue and Market Share by Countries (2013-2018)
    • 7.2 China Gamma-Aminobutyric Acid (GABA) Receptor Sales and Growth Rate (2013-2018)
    • 7.3 Japan Gamma-Aminobutyric Acid (GABA) Receptor Sales and Growth Rate (2013-2018)
    • 7.4 Korea Gamma-Aminobutyric Acid (GABA) Receptor Sales and Growth Rate (2013-2018)
    • 7.5 India Gamma-Aminobutyric Acid (GABA) Receptor Sales and Growth Rate (2013-2018)
    • 7.6 Southeast Asia Gamma-Aminobutyric Acid (GABA) Receptor Sales and Growth Rate (2013-2018)

    8 South America Gamma-Aminobutyric Acid (GABA) Receptor by Countries

    • 8.1 South America Gamma-Aminobutyric Acid (GABA) Receptor Sales, Revenue and Market Share by Countries
      • 8.1.1 South America Gamma-Aminobutyric Acid (GABA) Receptor Sales and Market Share by Countries (2013-2018)
      • 8.1.2 South America Gamma-Aminobutyric Acid (GABA) Receptor Revenue and Market Share by Countries (2013-2018)
    • 8.2 Brazil Gamma-Aminobutyric Acid (GABA) Receptor Sales and Growth Rate (2013-2018)
    • 8.3 Argentina Gamma-Aminobutyric Acid (GABA) Receptor Sales and Growth Rate (2013-2018)
    • 8.4 Colombia Gamma-Aminobutyric Acid (GABA) Receptor Sales and Growth Rate (2013-2018)

    9 Middle East and Africa Gamma-Aminobutyric Acid (GABA) Receptor by Countries

    • 9.1 Middle East and Africa Gamma-Aminobutyric Acid (GABA) Receptor Sales, Revenue and Market Share by Countries
      • 9.1.1 Middle East and Africa Gamma-Aminobutyric Acid (GABA) Receptor Sales and Market Share by Countries (2013-2018)
      • 9.1.2 Middle East and Africa Gamma-Aminobutyric Acid (GABA) Receptor Revenue and Market Share by Countries (2013-2018)
    • 9.2 Saudi Arabia Gamma-Aminobutyric Acid (GABA) Receptor Sales and Growth Rate (2013-2018)
    • 9.3 UAE Gamma-Aminobutyric Acid (GABA) Receptor Sales and Growth Rate (2013-2018)
    • 9.4 Egypt Gamma-Aminobutyric Acid (GABA) Receptor Sales and Growth Rate (2013-2018)
    • 9.5 Nigeria Gamma-Aminobutyric Acid (GABA) Receptor Sales and Growth Rate (2013-2018)
    • 9.6 South Africa Gamma-Aminobutyric Acid (GABA) Receptor Sales and Growth Rate (2013-2018)

    10 Global Gamma-Aminobutyric Acid (GABA) Receptor Market Segment by Type

    • 10.1 Global Gamma-Aminobutyric Acid (GABA) Receptor Sales, Revenue and Market Share by Type (2013-2018)
      • 10.1.1 Global Gamma-Aminobutyric Acid (GABA) Receptor Sales and Market Share by Type (2013-2018)
      • 10.1.2 Global Gamma-Aminobutyric Acid (GABA) Receptor Revenue and Market Share by Type (2013-2018)
    • 10.2 GABAA Sales Growth and Price
      • 10.2.1 Global GABAA Sales Growth (2013-2018)
      • 10.2.2 Global GABAA Price (2013-2018)
    • 10.3 GABAB Sales Growth and Price
      • 10.3.1 Global GABAB Sales Growth (2013-2018)
      • 10.3.2 Global GABAB Price (2013-2018)

    11 Global Gamma-Aminobutyric Acid (GABA) Receptor Market Segment by Application

    • 11.1 Global Gamma-Aminobutyric Acid (GABA) Receptor Sales Market Share by Application (2013-2018)
    • 11.2 Attention Deficit Hyperactivity Disorder Sales Growth (2013-2018)
    • 11.3 Psychiatric Disorders Sales Growth (2013-2018)
    • 11.4 Alzheimer's Disease Sales Growth (2013-2018)
    • 11.5 Chronic Obstructive Pulmonary Disease Sales Growth (2013-2018)
    • 11.6 Memory Impairment Sales Growth (2013-2018)
    • 11.7 Other Sales Growth (2013-2018)

    12 Gamma-Aminobutyric Acid (GABA) Receptor Market Forecast (2018-2023)

    • 12.1 Global Gamma-Aminobutyric Acid (GABA) Receptor Sales, Revenue and Growth Rate (2018-2023)
    • 12.2 Gamma-Aminobutyric Acid (GABA) Receptor Market Forecast by Regions (2018-2023)
      • 12.2.1 North America Gamma-Aminobutyric Acid (GABA) Receptor Market Forecast (2018-2023)
      • 12.2.2 Europe Gamma-Aminobutyric Acid (GABA) Receptor Market Forecast (2018-2023)
      • 12.2.3 Asia-Pacific Gamma-Aminobutyric Acid (GABA) Receptor Market Forecast (2018-2023)
      • 12.2.4 South America Gamma-Aminobutyric Acid (GABA) Receptor Market Forecast (2018-2023)
      • 12.2.5 Middle East and Africa Gamma-Aminobutyric Acid (GABA) Receptor Market Forecast (2018-2023)
    • 12.3 Gamma-Aminobutyric Acid (GABA) Receptor Market Forecast by Type (2018-2023)
      • 12.3.1 Global Gamma-Aminobutyric Acid (GABA) Receptor Sales Forecast by Type (2018-2023)
      • 12.3.2 Global Gamma-Aminobutyric Acid (GABA) Receptor Market Share Forecast by Type (2018-2023)
    • 12.4 Gamma-Aminobutyric Acid (GABA) Receptor Market Forecast by Application (2018-2023)
      • 12.4.1 Global Gamma-Aminobutyric Acid (GABA) Receptor Sales Forecast by Application (2018-2023)
      • 12.4.2 Global Gamma-Aminobutyric Acid (GABA) Receptor Market Share Forecast by Application (2018-2023)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Gamma-Aminobutyric Acid (GABA) Receptor . Industry analysis & Market Report on Gamma-Aminobutyric Acid (GABA) Receptor is a syndicated market report, published as Global Gamma-Aminobutyric Acid (GABA) Receptor Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Gamma-Aminobutyric Acid (GABA) Receptor market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,787.48
      4,181.22
      5,574.96
      3,250.32
      4,875.48
      6,500.64
      548,065.20
      822,097.80
      1,096,130.40
      290,197.20
      435,295.80
      580,394.40
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report